ArticlePharmaceuticals (Basel, Switzerland)2025
Large-Scale Transcriptome Profiling and Network Pharmacology Analysis Reveal the Multi-Target Inhibitory Mechanism of Modified Guizhi Fuling Decoction in Prostate Cancer Cells.
Guochen Zhang, Lei Xiang, Qingzhou Li, Mingming Wei, Xiankuo Yu, Yan Luo, Jianping Chen, Xilinqiqige Bao, Dong Wang, Shiyi Zhou
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Guochen ZhangSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Lei XiangSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Qingzhou LiSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Mingming WeiSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Xiankuo YuSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Yan LuoSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.ORCID 0000-0002-8737-3082 Jianping ChenLKS Faculty of Medicine, School of Chinese Medical, The University of Hong Kong, Hong Kong 999077, China.ORCID 0000-0001-6494-5271 Xilinqiqige BaoMedical Innovation Center for Nationalities, Inner Mongolia Medical University, Hohhot City 010110, China.
Dong WangSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.ORCID 0000-0001-7877-7440 Shiyi ZhouSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Funding
Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine No. ZYYCXTD-D-202209Key Projects of Science and Technology Plan of Inner Mongolia Autonomous Region Grant No. 201802115Sichuan Provincial Administration of Traditional Chinese Medicine 2020JC0028
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
bioinformaticsHTS2 technologyModified Guizhi Fuling Decoctionnetwork pharmacologyprostate cancertranscriptomics
Identifiers
PMID41011149
PMCPMC12472799
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390